NiraWave™ nano 780 is a nanoparticulate near-infrared fluorescence imaging agent developed for high-resolution visualization of vascular architecture and angiogenic processes in preclinical models. Its optical profile supports sensitive detection of vascular fine structure while enabling assessment of tumor- and inflammation-associated angiogenesis.
The agent combines a broad excitation range with high quantum yield and near-infrared emission, supporting deep tissue imaging and reduced background autofluorescence in small animal studies.
NiraWave™ nano 780 is suitable for:
Emission wavelength: 780 nm
Excitation wavelength: below 740 nm
Near-infrared emission supports improved tissue penetration and enhanced vessel-to-background contrast in vivo.
Left: Optical angiography in mouse injected with NiraWave nano 780. The fine structure of blood vessels is clearly visible, for example, in the hind limbs.
Right: Color-coded image of the same animal showing a vascularized tumor in the hind limb.
In mouse optical angiography studies, NiraWave™ nano 780 enables clear delineation of vascular fine structures, including vessels in the hind limbs and peripheral circulation. In tumor-bearing animals, color-coded imaging highlights vascularized tumor regions, facilitating assessment of tumor-associated angiogenesis.
Absorption and emission spectra confirm stable optical performance suitable for quantitative imaging workflows.
NiraWave™ nano 780 is available in single and multi-injection formats. Ordering through an authorized distributor ensures consistent product quality, technical assistance, and support for experimental planning in preclinical vascular imaging studies.
Data sheets and supporting technical documentation are available to assist with protocol development and imaging optimization.
Authorized distributor of Viscover products by Nanopet Pharma GmbH. This page contains original distributor-specific content for preclinical optical angiography applications.
Price range: USD $632 through USD $2,894
